Back
iShares iBoxx $ High Yield Corporate Bond ETF Vs. Novo Nordisk AS Industry Stock Comparison
Sell
21
HYG
iShares iBoxx $ High Yield Corporate Bond ETF
Last Price:
$78.60
Seasonality Move:
-0.7%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
21
iShares iBoxx $ High Yield Corporate Bond ETF (HYG)
is a Sell
Is iShares iBoxx $ High Yield Corporate Bond ETF a Buy, Sell or Hold?
-
The current iShares iBoxx $ High Yield Corporate Bond ETF [HYG] share price is $78.58. The Score for HYG is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
HYG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HYG Stock Price Chart
What is iShares iBoxx $ High Yield Corporate Bond ETF's stock price today?
-
The iShares iBoxx $ High Yield Corporate Bond ETF share price today is $78.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HYG is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
HYG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 37.27 | Sell |
Chaikin Money Flow: | 45104597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (78.99 - 79.97) | Sell |
Bollinger Bands (100): | (78.68 - 79.94) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 19.69 | Sell |
Chaikin Money Flow: | 20899665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.63 - 110.99) | Sell |
Bollinger Bands (100): | (107.27 - 131.41) | Sell |
HYG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.09 | Sell |
20-day SMA: | 79.5 | Sell |
50-day SMA: | 79.45 | Sell |
200-day SMA: | 78.25 | Buy |
8-day EMA: | 78.92 | Sell |
20-day EMA: | 79.28 | Sell |
50-day EMA: | 79.39 | Sell |
200-day EMA: | 78.4 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.71 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 109.28 | Sell |
200-day SMA: | 126.25 | Sell |
8-day EMA: | 102.07 | Sell |
20-day EMA: | 105.53 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 118.09 | Sell |
iShares iBoxx $ High Yield Corporate Bond ETF Earnings Growth & HYG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
iShares iBoxx $ High Yield Corporate Bond ETF Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |